PWMG
IMGN

Prestige Wealth Management Group’s Immunogen Inc IMGN Stock Holding History

Prestige Wealth Management Group’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-423
Closed -$12.5K – 1057
2023
Q4 		$12.5K Hold
423
– – ﹤0.01% 409
2023
Q3 		$6.71K Hold
423
– – ﹤0.01% 516
2023
Q2 		$7.98K Hold
423
– – ﹤0.01% 506
2023
Q1 		$1.63K Hold
423
– – ﹤0.01% 786
2022
Q4 		$2.1K Hold
423
– – ﹤0.01% 823
2022
Q3 		$2K Hold
423
– – ﹤0.01% 794
2022
Q2 		$2K Hold
423
– – ﹤0.01% 810
2022
Q1 		$2K Hold
423
– – ﹤0.01% 827
2021
Q4 		$3K Hold
423
– – ﹤0.01% 758
2021
Q3 		$2K Hold
423
– – ﹤0.01% 841
2021
Q2 		$3K Hold
423
– – ﹤0.01% 760
2021
Q1 		$3K Hold
423
– – ﹤0.01% 754
2020
Q4 		$3K Sell
423
-297
-41% -$1.73K ﹤0.01% 721
2020
Q3 		$3K Hold
720
– – ﹤0.01% 658
2020
Q2 		$3K Hold
720
– – ﹤0.01% 648
2020
Q1 		$2K Buy
+720
New +$3.15K ﹤0.01% 697
2019
Q1 		– Sell
-720
Closed -$3K – 1192
2018
Q4 		$3K Buy
+720
New +$4.37K ﹤0.01% 769

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Prestige Wealth Management Group's IMGN Position: Q1 2024 in Review

Prestige Wealth Management Group sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 423 shares — an estimated $12.5K sold.

Prestige Wealth Management Group first reported a position in IMGN in Q4 2018 and held it in 17 quarters. The position peaked at $12.5K in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Prestige Wealth Management Group reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Prestige Wealth Management Group sold 423 Immunogen Inc shares in Q1 2024, an estimated $12.5K.
  • Prestige Wealth Management Group first reported a position in Immunogen Inc in Q4 2018 and held it in 17 quarters.
  • Prestige Wealth Management Group's Immunogen Inc position peaked at $12.5K in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Prestige Wealth Management Group's 13F filing for Q1 2024, filed 26 Apr 2024.